ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

MLSS vs HSCS // NET PROFIT MARGIN

Milestone Scientific Inc. (NYSE) VS. HeartSciences Inc. (NASDAQ) • 15-METRIC TALLY: MLSS 4 — HSCS 1
▲ NET PROFIT MARGIN LEADER: MLSS
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MLSS VS. HSCS) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC MLSS HSCS SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 71.40% 59.10% +12.30 MLSS /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield -10.27% — — TIE /fcf-yield <GO>
Operating Margin -60.00% -60.00% 0.00 TIE /operating-margins <GO>
Net Profit Margin ACTIVE 63.80% -60.00% +123.80 MLSS /net-margins <GO>
Revenue Growth (YoY) — -0.70% — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 4/9 2/9 +2.00 MLSS /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 40.8 53.1 -12.30 HSCS /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple 4.7x — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $28.6M $17.5M $11.1M MLSS /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR MLSS REV HSCS REV MLSS GROSS % HSCS GROSS % MLSS FCF HSCS FCF
FY 2025 $9.0M $4.3K 71.4% 59.1% -$2.9M -$7.4M
FY 2024 $8.6M $4.3K 74.6% 56.8% -$2.9M -$7.4M
FY 2023 $0 $18.6K — — -$5.3M -$6.1M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MLSS // BETA —
HSCS // BETA —